CTRI/2021/07/034856尚未招募未知
The Expression of CD30 in Diffuse Large B-cell Lymphoma by Immunohistochemistry
Maulana Azad Medical College and Associated Hospitals0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •ALL THE DIAGNOSED CASES OF DIFFUSE LARGE B CELL LYMPHOMA NOT ON TREATMENT.
排除标准
- •ALL OTHER HEMATO-LYMPHOID MALIGNANCY
研究者
相似试验
已完成
3 期
Study of Recombinant Human-Mouse Chimeric Anti-CD20 Monoclonal Antibody to Treat Non-hodgkin's LymphomaDiffuse Large B Cell LymphomaNCT01459887Shanghai CP Guojian Pharmaceutical Co., Ltd.278
尚未招募
不适用
To assess frequency of Diffuse Large B Cell Lymphoma genetic subtypes in IndiaCTRI/2018/10/016107Duke Cancer Institute for Genome Science and Policy
已完成
不适用
A Study of Chinese Adults With LymphomaLymphomaNCT05288491Takeda934
已完成
不适用
BMS_PD-L1_onco : Assessment of the PD-L1 Protein as a Biomarker in Oncology and HematologyDiffuse Large B-cell LymphomaMetastatic BreastcancerNon-small Cell Lung CancerHodgkin LymphomaNCT01660776Rennes University Hospital105
招募中
1 期
CD30 CAR T Cells, Relapsed CD30 Expressing Lymphoma (RELY-30)Hodgkin's LymphomaNon-Hodgkin LymphomaNCT02917083Baylor College of Medicine60